4/5/2022 7:09:38 AM
Nurix Therapeutics Doses First Patient In Phase 1 Clinical Trial Of DeTIL-0255 For Solid Tumors
3/16/2021 9:52:43 AM
Nurix Announces Collaboration For The Discovery Of Novel Drugs To Treat Pediatric Cancers
3/4/2021 9:09:13 PM
Nurix Therapeutics Prices Public Offering Of 4.50 Mln Shares At $31.00/shr
1/7/2021 7:03:28 AM
Nurix Therapeutics Announces Expansion Of Its Global Strategic Collaboration With Sanofi